). The drug diluent is seen to be innocuous. Fig. 2 shows a typical graph of survival of lymphocytes that are resistant to chlorambucil (Case 10, Table 11 ). Table I shows the results of the sensitivity tests on four normal subjects. The subjectsarearrangedaccordingtothesensitivityoftheirlymphocytesto0-5/tg./ml. of drug at 120 hours. It will be observed that the lymphocytes from two females and one male were classified as sensitive whereas those from the remaining male were only moderately sensitive. Fig. 3 and 4 illustrate the effects of the addition of mitogens on the action of the drug on lymphocyte cultures which were sampled daily up to 118 hours. Fig. 3 demonstrates that the addition of mitogens to resistant lymphocytes does not alter their sensitivity (Case No. 6, Table 11 ). Fig. 4 shows the effect of the addition of mitogens to lymphocytes that are sensitive to chlorambucil in-vitro. If the drug is present ab initio, the addition of mitogen 10 minutes afterwards does not alter the sensitivity pattern of the lymphocytes. On the other hand, if the drug is added three days after the mitogen, then at 5 days the lymphocytes are apparently resistant to chlorambucil. However it must be appreciated that the cells have only been exposed to clrug for 2 days (Case No. 1, Table 11 ).
DISCUSSION
Whilst assessing drug-induced chromosomal damage in vitro, it became apparent that the sensitivity to chlorambucil of the lymphocytes of normal controls and patients with chronic lymphocytic leukaemia could be estimated by a simple in-vitro test. In this test lymphocytes that had not been exposed to mitogens were treated with chlorambucil, the standard dose being 0-5 ltg. per ml. of culture medium. The lymphocytes were incubated at 37' C. and the number of surviving cells was counted in samples taken daily over a period of 5 days.
The most clear-cut differences between sensitive and resistant Po-pulations of lymphocytes were obtained after 5 days' incubation. The test cannot be used with lymphocytes that are sensitive to the manipulations preceding incubation because they give a low score of surviving cells in the absence of the drug.
In our experience a more reliable result is given by reading the tests from stained smears than by the use of the trypan blue dye exclusion test of ceu viability. Degenerating cells are "lost" from wet preparations but they show up in smears as smudges in which chromatin is identifiable. The stained smears also have the advantage of providing a permanent record of the test.
The sensitivity of lymphocytes to chlorambucil varies in normal controls. Using our criteria for scoring, the lymphocytes of one of the normal controls were only moderately sensitive to the standard dose of the drug: a score in the sensitive range was obtained by increasing the concentration of chlorambucil to I ag. per ml. of culture. Two patients had not been treated with chlorambucil, one (Case 4), had lymphocytes which were only moderately sensitive to the drug, the other (Case 6), had cells that were resistant. Thus resistance of lymphocytes to chlorambucil in the in-vitro test amongst patients with chronic lymphocytic leukaemia can be present in the absence of in vivo experience of the drug. This is in accord with the observation of " natural " resistance of the disease process to chlorambucil therapy (Larionov, 1962) . The other patients with resistant lymphocytes (Cases 7, 8, 9, 10, 11 and 12) had all been treated with chlorambucil at some time during the course of their disease. The lymphocytes of these patients were still resistant when exposed to concentrations of drug up to I Itg. per ml. of culture. Most of the patients whose lymphocytes showed resistance had very high total lymphocyte counts, whilst patients whose lymphocytes were sensitive included those with both high and low total counts. Drug resistance was not necessarily a feature of old age.
The experiments in which the lymphocytes were exposed to -both mitogenic (Fig. 4) (Hill, 1968; Harrap andHill,personalcommunication,1971 The assessment of the accord between the in-vitro culture test of sensitivity and the response of the patients to chlorambucil is complicated by the fact that some of the patients have not been treated with the drug, whilst others have had other forms of therapy concomitantly. Where it has been possible to make a clinical judgement as to whether the patient was responding to chlorambucil at a par-ticular time, there is agreement with the results of the in-vitro test (GaltoD, personal communication, 1971 
